Hereditary Panel B analyzes inherited 69 genes associated with the most common types of cancer, detecting germline mutations that may increase an individual's risk of developing cancer. This focused panel supports early risk identification, clinical decision-making, and personalized care pathways for individuals and families with a history of cancer.
Yes. A healthcare provider will need to order the test. They will explain the results and help you decide what steps to take if a genetic risk is found.
Let’s Decode the Future of Health — Together
Get in touch today — let’s start a conversation that could change lives
*All information is handled with strict confidentiality.
Find Answers Today
Early detection saves lives
*All information is handled with strict confidentiality.